THE EFFECT OF MUSİC THERAPY IN HEMODİALYSİS PATİENTS
EFFECTİVENESS OF MUSİC THERAPY ON PAİN, ANXİETY AND LİFE PARAMETERS OF HEMODİALYSİS PATİENTS
1 other identifier
interventional
68
1 country
1
Brief Summary
The aim of this study is to evaluate the effects of music therapy on pain intensity, anxiety levels, and hemodynamics (vital signs) in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis. This study employs a quasi-experimental design with a pretest-posttest control group, conducted among patients receiving routine hemodialysis treatment at the DaViVa Göztepe Dialysis Center. Participants in the intervention group receive music therapy applied in 30-minute sessions at the beginning of each hour throughout their hemodialysis treatments (specifically during vascular access/cannulation and dialytic sessions), while the control group receives standard nursing care. Objective physiological parameters along with validated subjective pain and anxiety scales are measured before and after the intervention to determine the therapeutic efficacy of music as a non-pharmacological nursing intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2025
CompletedFirst Submitted
Initial submission to the registry
August 8, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
August 1, 2026
14 days
August 8, 2026
August 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of Pain
Scale Name: Visual Analog Scale (VAS) for Pain / Perceived Pain Severity Description: The Visual Analog Scale (VAS) is a validated, unidimensional, continuous measuring instrument used to assess subjective pain intensity. It consists of a horizontal straight line, typically 100 millimeters (or 10 centimeters) in length, anchored by two extreme verbal descriptors: "0" representing "No Pain" at the left endpoint and "10" (or "100 mm") representing "Worst Possible Pain / Unbearable Pain" at the right endpoint. Participants mark a point on the line corresponding to their currently perceived level of pain (specifically evaluated during arteriovenous fistula/graft cannulation and throughout the hemodialysis session). Pain intensity is measured in millimeters (0-100 mm) or centimeters (0-10 cm) from the left end to the patient's mark. Higher scores indicate greater pain severity.
Baseline and immediately after the intervention
Study Arms (2)
Control Group
NO INTERVENTIONParticipants in this group received no intervention and followed standard routıne procedures
Intervention Group
EXPERIMENTALParticipants in this grup received the experimental interventionin addition to standard care.
Interventions
Music therapy intervention was applied to participants in the experimental group during treatment sessions.
Eligibility Criteria
You may qualify if:
- Aged 18 years and older,
- Receiving hemodialysis (HD) treatment for at least 6 months,
- Scheduled for HD treatment 3 days a week,
- Free of hearing impairment,
- Voluntarily agreeing to participate in the study. -
You may not qualify if:
- Engaging in another complementary and integrative therapy,
- Unwilling to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Daviva Goztepe Dialysis Center
Izmir, 35390, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 8, 2026
First Posted
August 19, 2026
Study Start
June 23, 2025
Primary Completion
July 7, 2025
Study Completion
July 12, 2025
Last Updated
August 19, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect patient privacy and confidentiality.